FUJIFILM Biotechnologies Capacity Update – May 2026
Discover the latest mammalian cell culture bio-manufacturing capacity at FUJIFILM Biotechnologies.
Denmark at Scale: Powering Global Biomanufacturing
What does it take to build a biologics manufacturing network designed for speed, flexibility, and long-term partnership?
In this video, Christian Houborg, Senior Vice…
Turning Gene Therapies into Patient Reality: Large Scale Cost-Effective AAV Production
Samuel Hernandez, Ph.D. of FUJIFILM Biotechnologies explains why scaling AAV manufacturing is critical to expanding patient access to gene therapies.
An Innovative, Modular Approach to Flexible Supply Chain Management
Learn more about how FUJIFILM Biotechnologies takes an innovative and modular approach to flexible supply chain management.
Brochure: Cell & Gene Therapies
Learn more about FUJIFILM Biotechnologies' advanced therapies offering, including cell therapy, iPSC-based therapies and technologies, and gene therapy.
Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark
Learn more about how FUJIFILM Biotechnologies’ Denmark site is expanding the biomanufacturing network with speed, scale, and reliability in mind.
A Precision Purification Technology for Microbial Biologics
Learn about how ShunzymeX™ simplifies downstream processing, streamlines purification of complex biologics, and accelerates microbial processes.
Can We Truly Deliver Gene Therapies to Patients Without Solving the Cost and Scale Challenges of AAV Production?
Samuel Hernandez, Ph.D. of FUJIFILM Biotechnologies discusses AAV production and what it takes to support reliable commercial supply for gene therapies.
April 2026 Newsletter
Read up on FUJIFILM Biotechnologies' April 2026 Special Edition of the IN FOCUS Newsletter.
Borealis: Flexible Single-Use Biomanufacturing and kojoX Continuous Scaling
Inside Borealis - our single-use facility enabling scale-out and scale-on continuous processing via kojoX. Interview with Azam Razzaq.